ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
235.88
-0.22 (-0.09%)
At close: Apr 25, 2025, 4:00 PM
237.00
+1.12 (0.47%)
After-hours: Apr 25, 2025, 6:31 PM EDT

ResMed Market Cap

ResMed has a market cap or net worth of $34.59 billion as of April 25, 2025. Its market cap has increased by 21.33% in one year.

Market Cap
34.59B
Enterprise Value
34.48B
1-Year Change
21.33%
Ranking
Category
Stock Price
$235.88

Market Cap Chart

Since December 1, 1998, ResMed's market cap has increased from $485.80M to $34.59B, an increase of 7,019.49%. That is a compound annual growth rate of 17.52%.

History

DateMarket Cap% Change
Apr 25, 202534.59B3.03%
Dec 31, 202433.57B32.68%
Dec 29, 202325.30B-17.01%
Dec 30, 202230.49B-19.68%
Dec 31, 202137.96B23.23%
Dec 31, 202030.80B38.24%
Dec 31, 201922.28B37.32%
Dec 31, 201816.23B35.02%
Dec 29, 201712.02B37.39%
Dec 30, 20168.75B16.66%
Dec 31, 20157.50B-4.09%
Dec 31, 20147.82B16.86%
Dec 31, 20136.69B12.47%
Dec 31, 20125.95B40.80%
Dec 30, 20114.22B-19.35%
Dec 31, 20105.24B33.67%
Dec 31, 20093.92B38.11%
Dec 31, 20082.84B-30.14%
Dec 31, 20074.06B8.50%
Dec 29, 20063.74B38.30%
Dec 30, 20052.71B56.41%
Dec 31, 20041.73B22.93%
Dec 31, 20031.41B39.73%
Dec 31, 20021.01B-41.47%
Dec 31, 20011.72B39.28%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 794.31B
UnitedHealth Group 381.06B
Johnson & Johnson 371.93B
AbbVie 329.14B
Novo Nordisk 272.76B
Abbott Laboratories 223.47B
AstraZeneca 214.65B
Novartis AG 211.71B
Market Cap Rankings